Exactly, capital raising is the biggest risk at this stage imo....

Exactly, capital raising is the biggest risk at this stage imo. It will only be more difficult to rasie fund in the future given cash rate is going up continously. Totally agree that we really need to partner asap, otherwise I can't imagine how low we'd have to go to raise money.

After dose selection, we will have 1170 participants to be screened for Para 002 stage 2 and Para 003 trials. This is a long long way that will incur significant trial costs. I really want to know how much money they need to run these large trials, and we do need a great CFO to work on these costs.